Natural products as a source for treating neglected parasitic diseases

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 3395-3439

  Ndjonka, Dieudonné ^a   Rapado, Ludmila Nakamura ^b   Silber, Ariel M ^b   Liebau, Eva ^c   Wrenger, Carsten ^b  

^a UNIVERSITY OF NGAOUNDERE   (Cameroon)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Institute of Zoophysiology   (Germany)

Author keywords

Natural compounds; Neglected infectious diseases; River blindness; Schistosomiasis; Trypanosomatids

Indexed keywords

ACER RUBRUM EXTRACT; ALBENDAZOLE; ANNONA SENEGALENSIS EXTRACT; ANOGEISSUS LEIOCARPUS EXTRACT; ANTIFILARIAL AGENT; ANTIPARASITIC AGENT; ARTEMISIA ANNUA EXTRACT; CLEOME DROSERIFOLIA EXTRACT; CLERODENDRUM UMBELLATUM EXTRACT; CURCUMA LONGA EXTRACT; DIETHYLCARBAMAZINE; ELLAGIC ACID; EUPHORBIA HIRTA EXTRACT; GALLIC ACID; GENTISIC ACID; HAGENIA ABYSSINICA EXTRACT; HOMALIUM AFRICANUM EXTRACT; IVERMECTIN; KHAYA SENEGALENSIS EXTRACT; LESPEDEZA CUNEATA EXTRACT; LEVAMISOLE; MARGARITARIA DISCOIDEA EXTRACT; NATURAL PRODUCT; PARQUETINA NIGRESCENS EXTRACT; PLANT EXTRACT; QUERCUS ALBA EXTRACT; RHUS TYPHINA EXTRACT; ROSA MULTIFLORA EXTRACT; TANNIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACER RUBRUM; ANNONACEAE; ANOGEISSUS LEIOCARPUS; ANTHELMINTIC ACTIVITY; ANTIBIOTIC THERAPY; BARK; CAENORHABDITIS ELEGANS; CHEMICAL MODIFICATION; DRUG POTENCY; DRUG SYNTHESIS; DRUG TARGETING; EUPHORBIACEAE; FILARIASIS; HAGENIA ABYSSINICA; HEALTH CARE NEED; HOMALIUM AFRICANUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KHAYA SENEGALENSIS; LESPEDEZA CUNEATA; LYMPHATIC FILARIASIS; MARGARITARIA DISCOIDEA; MEDICINAL PLANT; MICROBIAL GROWTH; NEGLECTED DISEASE; NEMATODE; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE CONTROL; PARASITE LOAD; PARASITOSIS; PARQUETINA NIGRESCENS; PHYTOCHEMISTRY; PLANT LEAF; PLANT ROOT; PRIMARY HEALTH CARE; QUERCUS ALBA; REVIEW; RHUS TYPHINA; ROSA MULTIFLORA; SCHISTOSOMIASIS; SIMULIUM DAMNOSUM; TRADITIONAL MEDICINE; VECTOR CONTROL;

EID: 84875084369     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14023395     Document Type: Review

References (160)

1. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.; Biavatti, M.W.; Brun, R.; Da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.; et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part II. Curr. Med. Chem. 2012, 19, 2176-2228.
2. Schmidt, T.J.; Khalid, S.A.; Romanha, A.J.; Alves, T.M.; Biavatti, M.W.; Brun, R.; Da Costa, F.B.; de Castro, S.L.; Ferreira, V.F.; de Lacerda, M.V.; et al. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part I. Curr. Med. Chem. 2012, 19, 2128-2175.
3. Christen, P.C. Muriel plants as a source of therapeutic and health products. CHIMIA Int. J. Chem. 2012, 66, 320-323.
4. Ioset, J.R. Natural products for neglected diseases: A review. Curr. Organ. Chem. 2008, 12, 643-666.
5. Cavalier-Smith, T. A revised six-kingdom system of life. Biol. Rev. Camb. Philos. Soc. 1998, 73, 203-266.
6. Lambshead, P.J.D. Recent developments in marine benthic biodiversity research. Oceanis 1993, 19, 5-24.
7. Hugot, J.P.; Baujard, P.; Morand, S. Biodiversity in helminths and nematodes as a field of study: An overview. Nematology 2001, 3, 199-208.
8. World Health Organization. Onchocerciasis and Its Control; Report of 512 a WHO Expert Committee on Onchocerciasis Control. Geneva; WHO Technical 513 Report Series; WHO: Geneva, Switzerland, 1995; pp. 1-104.
9. Osei-Atweneboana, M.Y.; Eng, J.K.; Boakye, D.A.; Gyapong, J.O.; Prichard, R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: A two-phase epidemiological study. Lancet 2007, 369, 2021-2029.
10. Wagman, R.J.E. The New Complete Medical and Health Encyclopedia; Lexicon Publication Inc.: New York, NY, USA, 1982; Volume 4, p. 1310.
11. Navaratnam, V. Recent Advances in the Chemotheraphy of Lymphatic Filariasis. In Proceeding of 34th SEAMEO TROPMED Regional Seminar: Current Status of Filariasis in Southeast Asia, Kuala Lumpur, Malaysia, 26-27 June 1992.
12. World Health Organization. Global programme to eliminate lymphatic filariasis. Wkly. Epidemiol. Rec. 2009, 437-444.
13. Gyapong, J.O.; Kumaraswami, V.; Biswas, G.; Ottesen, E.A. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin. Pharmacother. 2005, 6, 179-200.
14. Bockarie, M.J.; Taylor, M.J.; Gyapong, J.O. Current practices in the management of lymphatic filariasis. Expert Rev. Anti-Infect. Ther. 2009, 7, 595-605.
15. Liang, J.L.; King, J.D.; Ichimori, K.; Handzel, T.; Pa'au, M.; Lammie, P.J. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa. Am. J. Trop. Med. Hyg. 2008, 78, 924-928.
16. The Carter Center. Available online: http://www.cartercenter.org/health/lf/index.html (accessed on 29 December 2012).
17. The Center of Disease Control and Prevention. Available online: http://www.cartercenter.org/ health/lf/index.html (accessed on 29 December 2012).
18. Winnen, M.; Plaisier, A.P.; Alley, E.S.; Nagelkerke, N.J.; van Oortmarssen, G.; Boatin, B.A.; Habbema, J.D. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ. 2002, 80, 384-391.
19. Kaplan, R.M. Drug resistance in nematodes of veterinary importance: A status report. Trends Parasitol. 2004, 20, 477-481.
20. Howell, S.B.; Burke, J.M.; Miller, J.E.; Terrill, T.H.; Valencia, E.; Williams, M.J.; Williamson, L.H.; Zajac, A.M.; Kaplan, R.M. Prevalence of anthelmintic resistance on sheep and goat farms in the southeastern United States. J. Am. Vet. Med. Assoc. 2008, 233, 1913-1919.
21. Moussala, M.; Fobi, G.; Zogo, O.; Hiag, B.L.A.; Bengono, G.; McMoli, T.E. Survenue d'hémorragies rétiniennes lors du traitement de l'onchocercose par l'invermectine chez une patiente co-infectée par la loase. J. Français d'Ophtalmologie 2004, 27, 63-66.
22. Melo, A.C.F.L.; Reis, I.F.; Bevilaqua, C.M.L.; Vieira, L.S.; Echevarria, F.M.; Melo, L.M. Nematodeos resistentes a anti-helminticos em rebanhos de ovinos ecaprinos do estado do Ceará, Brasil. Ciencia Rural 2003, 33, 339-344.
23. Sullivan, K.; Shealy, C.N. Complete Natural Home Remedies; Element Books Limited: Shafterburg, UK, 1997.
24. Robinson, M.M.; Zhang, X. Traditional Medicines: Global Situation, Issues and Challenges; WHO: Geneva, Switzerland, 2011.
25. Achukwi, M.D.; Harnett, W.; Renz, A. Onchocerca ochengi transmission dynamics and the correlation of O. ochengi microfilaria density in cattle with the transmission potential. Vet. Res. 2000, 31, 611-621.
26. Nyasse, B.; Ngantchou, I.; Nono, J.J.; Schneider, B. Antifilarial activity in vitro of polycarpol and 3-O-acetyl aleuritolic acid from cameroonian medicinal plants against Onchocerca gutturosa. Nat. Prod. Res. 2006, 20, 391-397.
27. Cho-Ngwa, F.; Abongwa, M.; Ngemenya, M.N.; Nyongbela, K.D. Selective activity of extracts of Margaritaria discoidea and Homalium africanum on Onchocerca ochengi. BMC Complement. Altern. Med. 2010, 10, 62.
28. Ndjonka, D.; Agyare, C.; Luersen, K.; Djafsia, B.; Achukwi, D.; Nukenine, E.N.; Hensel, A.; Liebau, E. In vitro activity of Cameroonian and Ghanaian medicinal plants on parasitic (Onchocerca ochengi) and free-living (Caenorhabditis elegans) nematodes. J. Helminthol. 2011, 85, 304-312.
29. Ndjonka, D.; Ajonina-Ekoti, I.; Djafsia, B.; Luersen, K.; Abladam, E.; Liebau, E. Anogeissus leiocarpus extract on the parasite nematode Onchocerca ochengi and on drug resistant mutant strains of the free-living nematode Caenorhabditis elegans. Vet. Parasitol. 2012, 190, 136-142.
30. Smith, R.A.; Pontiggia, L.; Waterman, C.; Lichtenwalner, M.; Wasserman, J. Comparison of motility, recovery, and methyl-thiazolyl-tetrazolium reduction assays for use in screening plant products for anthelmintic activity. Parasitol. Res. 2009, 105, 1339-1343.
31. Hoste, H.; Brunet, S.; Paolini, V.; Bahuaud, D.; Chauveau, S.; Fouraste, I.; Lefrileux, Y. Compared in vitro anthelmintic effects of eight tannin-rich plants browsed by goats in the southern part of France. Option Méditerrenéennes 2009, 431-436.
32. Thomsen, H.; Reider, K.; Franke, K.; Wessjohann, L.A.; Keiser, J.; Dagne, E.; Arnold, N. Characterization of constituents and anthelmintic properties of Hagenia abyssinica. Sci. Pharm. 2012, 80, 433-446.
33. Katiki, L.M.; Ferreira, J.F.; Gonzalez, J.M.; Zajac, A.M.; Lindsay, D.S.; Chagas, A.C.; Amarante, A.F. Anthelmintic effect of plant extracts containing condensed and hydrolyzable tannins on Caenorhabditis elegans, and their antioxidant capacity. Vet. Parasitol. 2012, 18, 218-227.
34. Lakshmi, V.; Kumar, R.; Gupta, P.; Varshney, V.; Srivastava, M.N.; Dikshit, M.; Murthy, P.K.; Misra-Bhattacharya, S. The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae. Parasitol. Res. 2004, 93, 468-474.
35. Fujimaki, Y.; Kamachi, T.; Yanagi, T.; Caceres, A.; Maki, J.; Aoki, Y. Macrofilaricidal and microfilaricidal effects of Neurolaena lobata, a Guatemalan medicinal plant, on Brugia pahangi. J. Helminthol. 2005, 79, 23-28.
36. Misra, N.; Sharma, M.; Raj, K.; Dangi, A.; Srivastava, S.; Misra-Bhattacharya, S. Chemical constituents and antifilarial activity of Lantana camara against human lymphatic filariid Brugia malayi and rodent filariid Acanthocheilonema viteae maintained in rodent hosts. Parasitol. Res. 2007, 100, 439-448.
37. Sahare, K.N.; Anandhraman, V.; Meshram, V.G.; Meshram, S.U.; Reddy, M.V.; Tumane, P.M.; Goswami, K. Anti-microfilarial activity of methanolic extract of Vitex negundo and Aegle marmelos and their phytochemical analysis. Indian J. Exp. Biol. 2008, 46, 128-131.
38. Sharma, R.D.; Veerpathran, A.R.; Dakshinamoorthy, G.; Sahare, K.N.; Goswami, K.; Reddy, M.V. Possible implication of oxidative stress in anti filarial effect of certain traditionally used medicinal plants in vitro against Brugia malayi microfilariae. Pharmacogn. Res. 2010, 2, 350-354.
39. Gaur, R.L.; Sahoo, M.K.; Dixit, S.; Fatma, N.; Rastogi, S.; Kulshreshtha, D.K.; Chatterjee, R.K.; Murthy, P.K. Antifilarial activity of Caesalpinia bonducella against experimental filarial infections. Indian J. Med. Res. 2008, 128, 65-70.
40. Mathew, N.; Misra-Bhattacharya, S.; Perumal, V.; Muthuswamy, K. Antifilarial lead molecules isolated from Trachyspermum ammi. Molecules 2008, 13, 2156-2168.
41. Singh, M.; Shakya, S.; Soni, V.K.; Dangi, A.; Kumar, N.; Bhattacharya, S.M. The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi. Int. Immunopharmacol. 2009, 9, 716-728.
42. Misra, S.; Verma, M.; Mishra, S.K.; Srivastava, S.; Lakshmi, V.; Misra-Bhattacharya, S. Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host. Parasitol. Res. 2011, 109, 1351-1360.
43. Zaridah, M.Z.; Idid, S.Z.; Omar, A.W.; Khozirah, S. In vitro antifilarial effects of three plant species against adult worms of subperiodic Brugia malayi. J. Ethnopharmacol. 2001, 78, 79-84.
44. Sashidhara, K.V.; Singh, S.P.; Misra, S.; Gupta, J.; Misra-Bhattacharya, S. Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi. Eur. J. Med. Chem. 2012, 50, 230-235.
45. Azeez, S.; Babu, R.O.; Aykkal, R.; Narayanan, R. Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of filarial nematodes. J. Mol. Model. 2012, 18, 151-163.
46. Kushwaha, S.; Roy, S.; Maity, R.; Mallick, A.; Soni, V.K.; Singh, P.K.; Chaurasiya, N.D.; Sangwan, R.S.; Misra-Bhattacharya, S.; Mandal, C. Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice. Vaccine 2012, 30, 1083-1093.
47. Kushwaha, S.; Soni, V.K.; Singh, P.K.; Bano, N.; Kumar, A.; Sangwan, R.S.; Misra-Bhattacharya, S. Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, NMITLI 128R and withaferin A protect Mastomys coucha from Brugia malayi infection. Parasite Immunol. 2012, 34, 199-209.
48. Salem, M.L. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int. Immunopharmacol. 2005, 5, 1749-1770.
49. Hoerauf, A.; Mand, S.; Fischer, K.; Kruppa, T.; Marfo-Debrekyei, Y.; Debrah, A.Y.; Pfarr, K.M.; Adjei, O.; Buttner, D.W. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med. Microbiol. Immunol. 2003, 192, 211-216.
50. Taylor, M.J.; Makunde, W.H.; McGarry, H.F.; Turner, J.D.; Mand, S.; Hoerauf, A. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: A double-blind, randomised placebo-controlled trial. Lancet 2005, 365, 2116-2121.
51. Sahare, K.N.; Anandharaman, V.; Meshram, V.G.; Meshram, S.U.; Gajalakshmi, D.; Goswami, K.; Reddy, M.V. In vitro effect of four herbal plants on the motility of Brugia malayi microfilariae. Indian J. Med. Res. 2008, 127, 467-471.
52. World Health Organization. Schistosomiasis: Population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol. Rec. 2012, 4, 37-44.
53. King, C.H. Parasites and poverty: The case of schistosomiasis. Acta Trop 2010, 113, 95-104.
54. Gray, D.J.; McManus, D.P.; Li, Y.; Williams, G.M.; Bergquist, R.; Ross, A.G. Schistosomiasis elimination: Lessons from the past guide the future. Lancet Infect. Dis. 2010, 10, 733-736.
55. Siddiqui, A.A.; Siddiqui, B.A.; Ganley-Leal, L. Schistosomiasis vaccines. Hum. Vaccin. 2011, 7, 1192-1197.
56. Gryseels, B.; Polman, K.; Clerinx, J.; Kestens, L. Human schistosomiasis. Lancet 2006, 368, 1106-1118.
57. Rollinson, D.; Knopp, S.; Levitz, S.; Stothard, J.R.; Tchuente, L.A.; Garba, A.; Mohammed, K.A.; Schur, N.; Person, B.; Colley, D.G.; et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2012, in press.
58. Fenwick, A.W., J.P. Schistosomiasis: Challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 2006, 19, 577-582.
59. Steinmann, P.; Keiser, J.; Bos, R.; Tanner, M.; Utzinger, J. Schistosomiasis and water resources development: Systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 2006, 6, 411-425.
60. Fenwick, A.; Savioli, L. Schistosomiasis elimination. Lancet Infect. Dis. 2011, 11, 346-347.
61. Rapado, L.N.; Nakano, E.; Ohlweiler, F.P.; Kato, M.J.; Yamaguchi, L.F.; Pereira, C.A.; Kawano, T. Molluscicidal and ovicidal activities of plant extracts of the Piperaceae on Biomphalaria glabrata (Say, 1818). J. Helminthol. 2011, 85, 66-72.
62. Chimbari, M.J. Enhancing schistosomiasis control strategy for zimbabwe: Building on past experiences. J. Parasitol. Res. 2012, 2012, doi:10.1155/2012/353768.
63. World Health Organization. Working to Overcome the Global Impact of Neglected Tropical Diseases-First WHO Report on Neglected Tropical Diseases; WHO Press: Geneva, Switzerland, 2010; p. 184.
64. Bueding, E.; Fisher, J. Factors affecting the inhibition of phosphofructokinase activity of Schistosoma mansoni by trivalent organic antimonials. Biochem. Pharmacol. 1966, 15, 1197-1211.
65. Cioli, D.; Pica-Mattoccia, L.; Archer, S. Antischistosomal drugs: Past, present and future? Pharmacol. Ther. 1995, 68, 35-85.
66. Denham DA, H.R. The effect of metrifonate in vitro on Schistosoma haematobium and S. mansoni adults. Trans. R. Soc. Trop. Med. Hyg. 1971, 65, 695-696.
67. Holmstedt, B.; Nordgren, I.; Sandoz, M.; Sundwall, A. Metrifonate. Summary of toxicological and pharmacological information available. Arch. Toxicol. 1978, 41, 3-29.
68. Cioli, D. Chemotherapy of schistosomiasis: An update. Parasitol. Today 1998, 14, 418-422.
69. Pica-Mattoccia, L.; Cioli, D. Studies on the mode of action of oxamniquine and related schistosomicidal drugs. Am. J. Trop. Med. Hyg. 1985, 34, 112-118.
70. Kohn, A.B.; Anderson, P.A.; Roberts-Misterly, J.M.; Greenberg, R.M. Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel. J. Biol. Chem. 2001, 276, 36873-36876.
71. Jeziorski, M.C.; Greenberg, R.M. Voltage-gated calcium channel subunits from platyhelminths: Potential role in praziquantel action. Int. J. Parasitol. 2006, 36, 625-632.
72. Salvador-Recatala, V.; Greenberg, R.M. Calcium channels of schistosomes: Unresolved questions and unexpected answers. Wiley Interdiscip. Rev. 2012, 1, 85-93.
73. Day, T.A.B.J.; Pax, R.A. Praziquantel: The enigmatic antiparasitic. Parasitol. Today 1992, 8, 342-344.
74. Utzinger, J.; Keiser, J.; Shuhua, X.; Tanner, M.; Singer, B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 2003, 47, 1487-1495.
75. Sabah, A.A.; Fletcher, C.; Webbe, G.; Doenhoff, M.J. Schistosoma mansoni: Chemotherapy of infections of different ages. Exp. Parasitol. 1986, 61, 294-303.
76. Fenwick, A.; Savioli, L.; Engels, D.; Robert Bergquist, N.; Todd, M.H. Drugs for the control of parasitic diseases: Current status and development in schistosomiasis. Trends Parasitol. 2003, 19, 509-515.
77. Doenhoff, M.J.; Hagan, P.; Cioli, D.; Southgate, V.; Pica-Mattoccia, L.; Botros, S.; Coles, G.; Tchuem Tchuente, L.A.; Mbaye, A.; Engels, D. Praziquantel: Its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 2009, 136, 1825-1835.
78. Utzinger, J.; N'Goran E, K.; Caffrey, C.R.; Keiser, J. From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop. 2011, 120, S121-S137.
79. Bennett, J.L.; Day, T.; Liang, F.T.; Ismail, M.; Farghaly, A. The development of resistance to anthelmintics: A perspective with an emphasis on the antischistosomal drug praziquantel. Exp. Parasitol. 1997, 87, 260-267.
80. Kusel, J.; Hagan, P. Praziquantel-its use, cost and possible development of resistance. Parasitol. Today 1999, 15, 352-354.
81. Ismail, M.; Botros, S.; Metwally, A.; William, S.; Farghally, A.; Tao, L.F.; Day, T.A.; Bennett, J.L. Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 1999, 60, 932-935.
82. Cioli, D. Praziquantel: Is there real resistance and are there alternatives? Curr. Opin. Infect. Dis. 2000, 13, 659-663.
83. Doenhoff, M.J.; Kusel, J.R.; Coles, G.C.; Cioli, D. Resistance of Schistosoma mansoni to praziquantel: Is there a problem? Trans. R. Soc. Trop. Med. Hyg. 2002, 96, 465-469.
84. Doenhoff, M.; Kimani, G.; Cioli, D. Praziquantel and the control of schistosomiasis. Parasitol. Today 2000, 16, 364-366.
85. Gryseels, B.; Mbaye, A.; de Vlas, S.J.; Stelma, F.F.; Guisse, F.; van Lieshout, L.; Faye, D.; Diop, M.; Ly, A.; Tchuem-Tchuente, L.A.; et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 2001, 6, 864-873.
86. Caffrey, C.R. Chemotherapy of schistosomiasis: Present and future. Curr. Opin. Chem. Biol. 2007, 11, 433-439.
87. Sabra, A.N.; Botros, S.S. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure. J. Parasitol. 2008, 94, 537-541.
88. Doenhoff, M.J.; Cioli, D.; Utzinger, J. Praziquantel: Mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21, 659-667.
89. Barakat, R.; El Morshedy, H. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt. Parasitology 2011, 138, 440-446.
90. Kayser, O.; Kiderlen, A.F.; Croft, S.L. Natural products as antiparasitic drugs. Parasitol. Res. 2003, 90, S55-S62.
91. Da Silva Filho, A.A.; Costa, E.S.; Cunha, W.R.; Silva, M.L.; Nanayakkara, N.P.; Bastos, J.K. In vitro antileishmanial and antimalarial activities of tetrahydrofuran lignans isolated from Nectandra megapotamica (Lauraceae). Phytother. Res. 2008, 22, 1307-1310.
92. Moraes, J.; Nascimento, C.; Lopes, P.O.; Nakano, E.; Yamaguchi, L.F.; Kato, M.J.; Kawano, T. Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp. Parasitol. 2011, 127, 357-364.
93. Ndamba, J.; Chidimu, M.G.; Zimba, M.; Gomo, E.; Munjoma, M. An investigation of the schistosomiasis transmission status in Harare. Cent. Afr. J. Med. 1994, 40, 337-342.
94. Clark, T.E.; Appleton, C.C.; Kvalsvig, J.D. Schistosomiasis and the use of indigenous plant molluscicides: A rural South African perspective. Acta Trop. 1997, 66, 93-107.
95. Sparg, S.G.; van Staden, J.; Jager, A.K. Efficiency of traditionally used South African plants against schistosomiasis. J. Ethnopharmacol. 2000, 73, 209-214.
96. Molgaard, P.; Nielsen, S.B.; Rasmussen, D.E.; Drummond, R.B.; Makaza, N.; Andreassen, J. Anthelmintic screening of Zimbabwean plants traditionally used against schistosomiasis. J. Ethnopharmacol. 2001, 74, 257-264.
97. Bah, S.; Diallo, D.; Dembele, S.; Paulsen, B.S. Ethnopharmacological survey of plants used for the treatment of schistosomiasis in Niono District, Mali. J. Ethnopharmacol. 2006, 105, 387-399.
98. Cunha, N.L.U.C.; Cintra, L.S.; Souza, H.C.; Peixoto, J.A.; Silva, C.P.; Magalhães, L.G.; Groppo, M.; Rodrigues, V.; Filho, A.A.S.; Silva, M.L.A.; et al. In Vitro schistosomicidal activity of some brazilian cerrado species and their isolated compounds. Evidence-Based Complement. Alter. Med. 2012, 2012, doi:10.1155/2012/173614.
99. Magalhaes, L.G.; Machado, C.B.; Morais, E.R.; Moreira, E.B.; Soares, C.S.; da Silva, S.H.; da Silva Filho, A.A.; Rodrigues, V. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res. 2009, 104, 1197-1201.
100. Magalhaes, L.G.; Kapadia, G.J.; da Silva Tonuci, L.R.; Caixeta, S.C.; Parreira, N.A.; Rodrigues, V.; da Silva Filho, A.A. In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol. Res. 2010, 106, 395-401.
101. Caixeta, S.C.; Melo, N.I.; Wakabayashi, K.A.L.; Aguiar, G.P.; Aguiar, D.P.; Mantovani, A.L.L.; Alves, J.M.; Oliveira, P.F.; Tavares, D.C.; Groppo, M.G.; et al. Chemical composition and in vitro schistosomicidal activity of the essential oil of Plectranthus neochilus grown in southeast Brazil. Chem. Biodivers. 2011, 8, 2147-2157.
102. Pereira, A.C.; Magalhaes, L.G.; Goncalves, U.O.; Luz, P.P.; Moraes, A.C.; Rodrigues, V.; da Matta Guedes, P.M.; da Silva Filho, A.A.; Cunha, W.R.; Bastos, J.K.; et al. Schistosomicidal and trypanocidal structure-activity relationships for (+/-)-licarin A and its (-)-and (+)-enantiomers. Phytochemistry 2011, 72, 1424-1430.
103. Moraes, J.; Nascimento, C.; Yamaguchi, L.F.; Kato, M.J.; Nakano, E. Schistosoma mansoni: In vitro schistosomicidal activity and tegumental alterations induced by piplartine on schistosomula. Exp. Parasitol. 2012, 132, 222-227.
104. Jisaka, M.; Kawanaka, M.; Sugiyama, H.; Takegawa, K.; Huffman, M.A.; Ohigashi, H.; Koshimizu, K. Antischistosomal activities of sesquiterpene lactones and steroid glucosides from Vernonia amygdalina, possibly used by wild chimpanzees against parasite-related diseases. Biosci. Biotechnol. Biochem. 1992, 56, 845-846.
105. McIntosh, H.M.; Olliaro, P. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst. Rev. 2000, CD000256.
106. Le, W.J.; You, J.Q.; Yang, Y.Q.; Mei, J.Y.; Guo, H.F.; Yang, H.Z.; Zhang, C.W. Studies on the efficacy of artemether in experimental schistosomiasis (author's transl). Yao Xue Xue Bao 1982, 17, 187-193.
107. Yue, W.J.; You, J.Q.; Mei, J.Y. Effects of artemether on Schistosoma japonicum adult worms and ova. Zhongguo Yao Li Xue Bao 1984, 5, 60-63.
108. Utzinger, J.; Xiao, S.; N'Goran, E.K.; Bergquist, R.; Tanner, M. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 2001, 31, 1549-1562.
109. Araujo, N.; Kohn, A.; Katz, N. Activity of the artemether in experimental schistosomiasis mansoni. Mem. Inst. Oswaldo Cruz 1991, 86, 185-188.
110. Utzinger, J.; N'Goran, E.K.; N'Dri, A.; Lengeler, C.; Xiao, S.; Tanner, M. Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial. Lancet 2000, 355, 1320-1325.
111. Keiser, J.; Chollet, J.; Xiao, S.H.; Mei, J.Y.; Jiao, P.Y.; Utzinger, J.; Tanner, M. Mefloquine-An aminoalcohol with promising antischistosomal properties in mice. PLoS Negl. Trop. Dis. 2009, 3, e350.
112. Erasmus, D.A. A comparative study of the reproductive system of mature, immature and "unisexual" female Schistosoma mansoni. Parasitology 1973, 67, 165-183.
113. Allam, G. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 2009, 214, 712-727.
114. Cichewicz, R.H.L.; McKerrow, JH; Nair, MG. Kwanzoquinones A-G and other constituents of Hemerocallis fulva "Kwanzo" roots and their activity against the human pathogenic trematode Schistosoma mansoni. Tetrahedron 2002, 58, 8597-8606.
115. El-Shenawy, N.S.; Soliman, M.F.; Abdel-Nabi, I.M. Does Cleome droserifolia have anti-schistosomiasis mansoni activity? Rev. Inst. Med. Trop. Sao Paulo 2006, 48, 223-228.
116. Jatsa, H.B.; Ngo Sock, E.T.; Tchuem Tchuente, L.A.; Kamtchouing, P. Evaluation of the in vivo activity of different concentrations of Clerodendrum umbellatum Poir against Schistosoma mansoni infection in mice. Afr. J. Tradit. Complement. Altern. Med. 2009, 6, 216-221.
117. Jiraungkoorskul, W.; Sahaphong, S.; Sobhon, P.; Riengrojpitak, S.; Kangwanrangsan, N. Schistosoma mekongi: The in vitro effect of praziquantel and artesunate on the adult fluke. Exp. Parasitol. 2006, 113, 16-23.
118. Utzinger, J.; Chollet, J.; Tu, Z.; Xiao, S.; Tanner, M. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans. R. Soc. Trop. Med. Hyg. 2002, 96, 318-323.
119. Lescano, S.Z.; Chieffi, P.P.; Canhassi, R.R.; Boulos, M.; Amato Neto, V. Antischistosomal activity of artemether in experimental Schistosomiasis mansoni. Rev. Saude Publica 2004, 38, 71-75.
120. Xiao, S.; Shen, B.; Chollet, J.; Utzinger, J.; Tanner, M. Tegumental changes in adult Schistosoma mansoni harbored in mice treated with artemether. J. Parasitol. 2000, 86, 1125-1132.
121. De Oliveira, C.B.; Comunello, L.N.; Lunardelli, A.; Amaral, R.H.; Pires, M.G.; da Silva, G.L.; Manfredini, V.; Vargas, C.R.; Gnoatto, S.C.; de Oliveira, J.R.; Gosmann, G. Phenolic enriched extract of Baccharis trimera presents anti-inflammatory and antioxidant activities. Molecules 2012, 17, 1113-1123.
122. Soliman, M.F. Evaluation of avocado/soybean unsaponifiable alone or concurrently with praziquantel in murine schistosomiasis. Acta Trop. 2012, 122, 261-266.
123. Lima, C.M.; Freitas, F.I.; Morais, L.C.; Cavalcanti, M.G.; Silva, L.F.; Padilha, R.J.; Barbosa, C.G.; Santos, F.A.; Alves, L.C.; Diniz Mde, F. Ultrastructural study on the morphological changes to male worms of Schistosoma mansoni after in vitro exposure to allicin. Rev. Soc. Bras. Med. Trop. 2011, 44, 327-330.
124. Race, G.J.; Martin, J.H.; Moore, D.V.; Larsh, J.E., Jr. Scanning and transmission electronmicroscopy of Schistosoma mansoni eggs, cercariae, and adults. Am. J. Trop. Med. Hyg. 1971, 20, 914-924.
125. Hockley, D.J. Ultrastructure of the tegument of Schistosoma. Adv Parasitol 1973, 11, 233-305.
126. Mitsui, Y.; Miura, M.; Aoki, Y. In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni. J Helminthol 2009, 83, 7-11.
127. Thompson, D.P.; Klein, R.D.; Geary, T.G. Prospects for rational approaches to anthelmintic discovery. Parasitology 1996, 113, S217-S238.
128. Sangster, N.C.; Song, J.; Demeler, J. Resistance as a tool for discovering and understanding targets in parasite neuromusculature. Parasitology 2005, 131, S179-S190.
129. Marks, N.J.; Maule, A.G. Neuropeptides in helminths: Occurrence and distribution. Adv. Exp. Med. Biol. 2010, 692, 49-77.
130. Taman, A.; Ribeiro, P. Glutamate-mediated signaling in Schistosoma mansoni: A novel glutamate receptor is expressed in neurons and the female reproductive tract. Mol. Biochem. Parasitol. 2011, 176, 42-50.
131. Hillman, G.R.; Gibler, W.B.; Chu, S.H. Fluorescent probes of acetylcholine binding sites-indicators of drug action in Schistosoma mansoni. Biochem. Pharmacol. 1976, 25, 2529-2535.
132. Bizimana, N.; Tietjen, U.; Zessin, K.H.; Diallo, D.; Djibril, C.; Melzig, M.F.; Clausen, P.H. Evaluation of medicinal plants from Mali for their in vitro and in vivo trypanocidal activity. J. Ethnopharmacol. 2006, 103, 350-356.
133. Freiburghaus, F.; Kaminsky, R.; Nkunya, M.H.; Brun, R. Evaluation of African medicinal plants for their in vitro trypanocidal activity. J. Ethnopharmacol. 1996, 55, 1-11.
134. Youan, B.B.; Coulibaly, S.; Miezan, T.B.; Doua, F.; Bamba, M. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense. Bull. World Health Organ. 1997, 75, 343-348.
135. Dua, V.K.; Verma, G.; Agarwal, D.D.; Kaiser, M.; Brun, R. Antiprotozoal activities of traditional medicinal plants from the Garhwal region of North West Himalaya, India. J. Ethnopharmacol. 2011, 136, 123-128.
136. Mann, A.; Ifarajimi, O.R.; Adewoye, A.T.; Ukam, C.; Udeme, E.E.; Okorie, II; Sakpe, M.S.; Ibrahim, D.R.; Yahaya, Y.A.; Kabir, A.Y.; et al. In vivo antitrypanosomal effects of some ethnomedicinal plants from Nupeland of north central Nigeria. Afr. J. Tradit. Complement. Altern. Med. 2011, 8, 15-21.
137. Buckner, F.S.N.N. Advances in Chagas disease drug development: 2009-2010. Curr. Opin. Infect. Dis. 2010, 23, 609-616.
138. Andrade e Silva, M.L.; Cicarelli, R.M.; Pauletti, P.M.; Luz, P.P.; Rezende, K.C.; Januario, A.H.; da Silva, R.; Pereira, A.C.; Bastos, J.K.; de Albuquerque, S.; et al. Trypanosoma cruzi: Evaluation of (-)-cubebin derivatives activity in the messenger RNAs processing. Parasitol. Res. 2011, 109, 445-451.
139. Parmar, V.S.J.; Gupta, S.; Talwar, S.; Rajwanshi, V.K.K.; Azim, A.; Malhotra, S.K.; Jain, R.; Sharma, N.K.; Tyagi, O.D.L.; Errington, W.; et al. Polyphenols and alkaloids from Piper species. Phytochemistry 1998, 49, 1069-1078.
140. Baldoqui, D.C.; Kato, M.J.; Cavalheiro, A.J.; Bolzani V.S.; Young, M.C.; Furlan, M.A. chromene and prenylated benzoic acid from Piper aduncum. Phytochemistry 1999, 51, 899-902.
141. Kato, M.J.; Furlan, M. Chemistry and evolution of the Piperaceae. Pure Appl. Chem. 2007, 79, 529-538.
142. Nour, A.M.; Khalid, S.A.; Kaiser, M.; Brun, R.; Abdallah, W.E.; Schmidt, T.J. The antiprotozoal activity of sixteen asteraceae species native to Sudan and bioactivity-guided isolation of xanthanolides from Xanthium brasilicum. Planta Med. 2009, 75, 1363-1368.
143. Batista, J.M., Jr.; Lopes, A.A.; Ambrosio, D.L.; Regasini, L.O.; Kato, M.J.; Bolzani V.S.; Cicarelli, R.M.; Furlan, M. Natural chromenes and chromene derivatives as potential anti-trypanosomal agents. Biol. Pharm. Bull. 2008, 31, 538-540.
144. Flores, N.; Jimenez, I.A.; Gimenez, A.; Ruiz, G.; Gutierrez, D.; Bourdy, G.; Bazzocchi, I.L. Antiparasitic activity of prenylated benzoic acid derivatives from Piper species. Phytochemistry 2009, 70, 621-627.
145. Flores, N.; Jimenez, I.A.; Gimenez, A.; Ruiz, G.; Gutierrez, D.; Bourdy, G.; Bazzocchi, I.L. Benzoic acid derivatives from Piper species and their antiparasitic activity. J. Nat. Prod. 2008, 71, 1538-1543.
146. Torres-Santos, E.C.; Moreira, D.L.; Kaplan, M.A.; Meirelles, M.N.; Rossi-Bergmann, B. Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 1999, 43, 1234-1241.
147. Hermoso, A.; Jimenez, I.A.; Mamani, Z.A.; Bazzocchi, I.L.; Pinero, J.E.; Ravelo, A.G.; Valladares, B. Antileishmanial activities of dihydrochalcones from Piper elongatum and synthetic related compounds. Structural requirements for activity. Bioorg. Med. Chem. 2003, 11, 3975-3980.
148. Bodiwala, H.S.S.G.; Singh, R.; Dey, C.S.; Sharma, S.S.; Bhutani, K.K.; Singh, I.P. Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum. J. Nat. Med. 2007, 61, 418-421.
149. Luize, P.S.; Ueda-Nakamura, T.; Dias Filho, B.P.; Cortez, D.A.; Nakamura, C.V. Activity of neolignans isolated from Piper regnellii (MIQ.) C. DC. var. pallescens against Trypanosoma cruzi. Biol. Pharm. Bull. 2006, 29, 2126-2130.
150. Martins, R.C.; Lago, J.H.; Albuquerque, S.; Kato, M.J. Trypanocidal tetrahydrofuran lignans from inflorescences of Piper solmsianum. Phytochemistry 2003, 64, 667-670.
151. Ribeiro, T.S.; Freire-de-Lima, L.; Previato, J.O.; Mendonca-Previato, L.; Heise, N.; de Lima, M.E. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi. Bioorg. Med. Chem. Lett. 2004, 14, 3555-3558.
152. Cotinguiba, F.R.; Bolzani, V.S.; Debonsi, H.M.; Passerini, G.D.; Cicarelli, R.M.B.; Kato, M.J.; Furlan, M. Piperamides and their derivatives as potential anti-trypanosomal agents. Med. Chem. Res. 2009, 18, 703-711.
153. Lopes, A.A.; Lopez, S.N.; Regasini, L.O.; Junior, J.M.; Ambrosio, D.L.; Kato, M.J.; da Silva Bolzani, V.; Cicarelli, R.M.; Furlan, M. In vitro activity of compounds isolated from Piper crassinervium against Trypanosoma cruzi. Nat. Prod. Res. 2008, 22, 1040-1046.
154. Ganfon, H.; Bero, J.; Tchinda, A.T.; Gbaguidi, F.; Gbenou, J.; Moudachirou, M.; Frederich, M.; Quetin-Leclercq, J. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C. J. Ethnopharmacol. 2012, 141, 411-417.
155. Nibret, E.; Ashour, M.L.; Rubanza, C.D.; Wink, M. Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities. Phytother. Res. 2010, 24, 945-947.
156. Oliveira, M.F.; d'Avila, J.C.; Tempone, A.J.; Soares, J.B.; Rumjanek, F.D.; Ferreira-Pereira, A.; Ferreira, S.T.; Oliveira, P.L. Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection. J. Infect. Dis. 2004, 190, 843-852.
157. Jones, A.K.; Bentley, G.N.; Oliveros Parra, W.G.; Agnew, A. Molecular characterization of an acetylcholinesterase implicated in the regulation of glucose scavenging by the parasite Schistosoma. FASEB J 2002, 16, 441-443.
158. Abdulla, M.H.; Ruelas, D.S.; Wolff, B.; Snedecor, J.; Lim, K.C.; Xu, F.; Renslo, A.R.; Williams, J.; McKerrow, J.H.; Caffrey, C.R. Drug discovery for schistosomiasis: Hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl. Trop. Dis. 2009, 3, e478.
159. Quezada, L.A.; McKerrow, J.H. Schistosome serine protease inhibitors: Parasite defense or homeostasis? An. Acad. Bras. Cienc. 2011, 83, 663-672.
160. Mendonca-Silva, D.L.; Pessoa, R.F.; Noel, F. Evidence for the presence of glutamatergic receptors in adult Schistosoma mansoni. Biochem. Pharmacol. 2002, 64, 1337-1344.